Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia

Area of Science:

• * Molecular biology
• * Genetics
• * Cancer research

Background:

• * Murine Moloney leukemia virus (MMLV)-based insertional mutagenesis identified preferential targeting of the Hoxa gene locus in E2A-PBX1-induced lymphoid leukemia.
• * Overexpression of Hoxa genes (Hoxa10, Hoxa9, Hoxa7) was observed, suggesting a functional link between Hox gene overexpression and E2A-PBX1 in lymphoid tumors.

Purpose of the Study:

• * To investigate the genetic interaction between E2A-PBX1 and Hox genes in the development of lymphoid leukemia in vivo.
• * To determine if Hox gene overexpression collaborates with E2A-PBX1 in T-cell transformation.

Main Methods:

• * Generation of compound E2A-PBX1 x Hox transgenic mice.
• * Assessment of T-cell leukemia onset and progression in transgenic and control littermates.
• * Quantitative analysis of Hoxa gene expression levels in different leukemia models.

Main Results:

• * Co-expression of E2A-PBX1 and Hoxb4 significantly accelerated the onset of T-cell leukemia compared to controls.
• * Hoxb4 demonstrated a more potent effect in accelerating leukemia than Hoxa9.
• * E2A-PBX1-induced T-cell leukemias exhibited higher Hoxa gene expression than MMLV-induced leukemias.

Conclusions:

• * This study provides the first genetic evidence for oncogenic collaboration between E2A-PBX1 and a Hox gene (Hoxb4) in lymphoid malignancies.
• * Specific Hoxa gene deregulation is documented in E2A-PBX1-mediated T-cell leukemias, suggesting their contribution to leukemogenesis.